Provisional patent for weight loss compound

By Kate McDonald
Friday, 27 February, 2009


Diagnostics company HealthLinx and industry group Dairy Australia have filed a provisional patent for a dairy-derived bioactive compound that has shown weight loss potential in rats.

The compound, LAP001, was identified from fractionated proteins in dairy products. It was found to reduce the production and storage of fat in rat cells.

The activity was confirmed by an independent research institute, HealthLinx said in a statement. Further analysis is being undertaken.

HealthLinx said there was the potential to develop the compound as a nutraceutical.

Related Articles

mRNA used to force HIV out of hiding

Using the same technology behind mRNA COVID-19 vaccines, researchers have discovered a way to...

Novel tool enables more precise gene therapy

A novel gene editor dubbed 'evoCAST' helps solve the problem of how to add long stretches...

Contact lens breakthrough lets humans see infrared light

Newly created contact lenses enable infrared vision in both humans and mice by converting...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd